跳至主要内容
临床试验/IRCT20181026041468N1
IRCT20181026041468N1尚未招募4 期

Comparing the Efficacy of Aripiprazole with other Second-Generation Antipsychotics in smoke cessation of inpatient Manic sufferers

Arak University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Bipolar disorder type-I patients in manic phase
  • older than 18
  • Informed consent

排除标准

  • Use of anti-psychotic medicines during the recent past 30 days
  • Use of ECT during the recent past 6 months
  • Pregnancy or breast-feeding
  • Alcohol dependence
  • Psychiatric disorders other than bipolar disorder
  • High risk of suicide
  • The use of mood stabilizers other than sodium valproate
  • liver disease
  • Positive history of polycystic ovaries
  • Thrombocytopenia

研究者

相似试验